SSTI Flashcards

1
Q

treatment of mild impetigo

A

topical antibiotics eg:

- mupirocin BD x 5/7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

empiric treatment of severe impetigo/ all ecthyma

A
  1. cephalexin 250-500mg PO QDS* x1/52
  2. cloxacillin 250-500mg PO QDS x1/52
  3. (penicillin allergy): clindamycin x1/52
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

culture directed treatment of severe impetigo/ all ecthyma

A

S pyogenes: penicilin VK 250-500mg PO QDS x1/52

MSSA:

  1. cephalexin 250-500mg PO QDS* x1/52
  2. cloxacillin 250-500mg PO QDS x1/52
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mainstay of treatment for purulent SSTI

A

incision and drainage (I&D)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

identify and treat mild, non purulent cellulitis/erysipelas

A

no signs of systemic infections (SIRS)
cover: strepto spp

treatment (PO)

  1. Penicillin VK
  2. Cloxacillin
  3. Cephalexin
  4. Clindamycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

identify and treat moderate, non purulent cellulitis/erysipelas

A
org to cover: strept +staph
if 1 SIRS: PO antibiotic
1. Penicillin VK
2. Cloxacillin
3. Cephalexin
4. Clindamycin

if >2 SIRS or PO Tx fail: IV

  1. Cefazolin
  2. Penicillin G
  3. Clindamycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

identify and treat severe, non-purulent cellulitis/erysipelas

A

org to cover: strept + staph+ gram neg (p. aeruginosa)

if >2 SIRS + BP<100-60/ rapid progression/immuno/comorbidities : IV

  1. Pipe-Tazo
  2. Cefepime
  3. Meropenem

MRSA risk factor: (immuno, critically ill, previous failure to non MRSA AB)- IV Tx:

  1. vanco (preferred- narrower)
  2. dapto
  3. Linezolid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

identify and treat mild, purulent cellulitis/erysipelas

A
organism: Strep& staph
no SIRS: PO
1. Cephalexin
2. Cloxacillin
3. Clindamycin

MRSA risk factor- (immuno, critically ill, previous failure to non MRSA AB) PO antibiotics Tx:

  1. Trimetho-Sulfametho
  2. Clindamycin
  3. Doxycycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

identify and treat moderate, purulent cellulitis/erysipelas

A

org: strep+staph

if 1 SIRS: treat like mild, PO

  1. Cefalexin
  2. Cloxacillin
  3. Clindamycin

if >2 SIRS: IV antibiotics

  1. Cefazolin
  2. Cloxacillin (milder +MRSA)
  3. Clindamycin (milder +MRSA)

MRSA risk- (immuno, critically ill, previous failure to non MRSA AB) IV antibiotics:

  1. vanco
  2. dapto
  3. linezolid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

identify and treat severe, purulent cellulitis/erysipelas

A

indications: >2SIRS, <100/60bpm, rapid progression, immuno, comorbidities

Organism: strepo + straph + gram neg (p aeruginosa)

Tx: IV antibiotics:

  1. Pipe-tazo
  2. Cefepime
  3. Meropenem

MRSA risk factors (immuno, critically ill, previous failure to non MRSA AB): IV

  1. Vanco
  2. Dapto
  3. Linezolid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

identify and treat mild DFI

A

infection of skin and SC tissue + erythema <=2cm around ulcer + no signs of systemic infection (no SIRS)

organism: strep/staph

treatment: PO antibiotics
1. Cephalexin
2. Cloxacillin
3. Clindamycin

MRSA risk factors (immuno, critically ill, previous failed AB without MRSA coverage): PO antibiotics

  1. Trimetho/Sulfametho
  2. Clindamycin
  3. Doxycycline

duration: 1-2w

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

identify and treat Moderate DFI

A

infection of skin and SC tissue + erythema >2cm around ulcer + no signs of systemic infection (no SIRS)

organism: strep/staph + gram neg (p.aeruginosa) + anaerobes

treatment: IV antibiotics
1. Amoxi/clav (dont need anaerobic coverage)
2. ceftriaxone
3. ertapenem (not really preferred; keep for esbl)

MRSA risk: IV

  1. vanco
  2. dapto
  3. linezolid

Anaerobes

  1. metronidazole
  2. clindamycin

duration: 1-3w

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

identify and treat severe DFI

A

signs of systemic infection (with SIRS)

organism: strep/staph + gram neg (p.aeruginosa) + anaerobes

Tx: initial IV

  1. pipe/tazo
  2. cefepime
  3. meropenem

MRSA risk: IV

  1. vanco
  2. Daptop
  3. Linezolid

anaerobic: IV
1. metronidazole
2. clindamycin

duration: 2-4w

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

duration of DFI tx

A

mild: 1-2w
moderate: 1-3w
severe: 2-4w
surgery remove all infected bone: 2-5d
surgery with residual infected soft tissues: 1-3w
surgery with residual viable bone: 4-6w
no surgery/ dead bone: >=3mth

dont continue AB until wound heals completely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

protective factors of skin

A
  1. drug surface (no moisture, prevent growth)
  2. fatty acids
  3. Acidic pH (~5.6)
  4. renewal of epidermis (skin shed)
  5. low temperature (inhibit bacteria growth)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

predisposing factors

A
  1. high bacteria innocula
  2. excessive moisture
  3. reduced blood supply
  4. presence of bacteria nutrients
  5. poor hygiene
  6. sharing of personal items
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

least to most deep SSTI

A
impetigo (epidermis)
ecthyma (dermis)
erysipelas (dermis)
furuncles (hair follicles)
carbuncles (hair follicles)
cellulitis (subcutaneous fat)
necrotising fascilitis (fascia)
myotitis (muscle)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how is impetigo and ecthyma usually managed and classified

A
outpatient;
severity: mild
depth of infection: uncomplicated
discharge: purulent/ non purulent
microbiology: primary
anatomical site: epidermis/ up to the dermal-epidermal junction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

scarring is common in ecthyma or impetigo

A

ecythma, it is deeper than impetigo

20
Q

causative agent of impetigo/ecthyma

A

staphlococcus aureus
B-hemolytic streptococci (pyrogenes)
bullous form caused by toxin-producing strains of S. aureus

21
Q

is culture a need for ecthyma or impetigo

A

it is optional; may culture if pus, but usually reasonable to treat without culture

22
Q

empirical coverage for ecthyma/impetigo

A

S. aureus and B-hemolytic streptococci (cover both since unsure which is the actual causative organism)

23
Q

furuncles

A

infection of the hair follicles, extended through the dermis, inflammatory nodule

24
Q

carbuncles

A

involved a few adjacent follicles; form a small abscess, , larger and deeper, multiple hair follicles may be involved

25
cutaneous abscesses
pus collection usually within dermis, nodule with rim of erythematous swelling, abscess may not be where hair follicles are
26
specific risk factors of purulent SSTI
close physical contact, crowded living quarters (dorms, camps, prison), sharing personal items, poor personal hygiene
27
causative organism of purulent SSTI
- staphylococcus aureus (single most common organism) | - large skin abscesses may be polymicrobial
28
need for culture for purulent SSTI?
usually treated without cultures since purulent causing organism are very predictable, but reasonable to culture
29
when to use adjunctive systemic antibiotic after I&D
1. unable to drain completely 2. lack of response of !&D 3. extensive disease involving several site 4. extreme age 5. immunosuppressed (chemo, transplant) 6. signs of systemic illness (SIRS)
30
SIRS criteria
1. temperature >38 degree or 36 degree 2. HR>90 beats/min 3. RR >24 bpm 4. WBC >12 or <4 x10^9/L
31
cellulitis
acute inflammation of epidermis, dermis and sometimes superficial fascia; bacteria can invade lymphatic tissue and blood; purulent or non-purulent, poorly demarcated area or erythema, purulent or non purulent
32
erysipelas
affects up to superficial dermis and lymphatic tissues; non-purulent; sharply demarcated area of erythema with raised border
33
complications of cellulitis or erysipelas
1. bacteremia 2. endocarditis 3. toxic shock 4. glomerulonephritis 5. lymphedema 6. osteomyelitis 7. necrotising soft-tissue infections (necrotising fasciitis)
34
causative organism for cellulitis & erysipelas
- staphlyococcus aureus (mainly purulent) - B-hemolytic streptococci (pyogenes)- 99% cause of erypelas - chronic liver/renal disease: vibrio, E.coli, pseudo. - immunosuppressed: strep pnuemoniae, E.coli, serratia marcescens, pseudo.
35
should cultures be done for cellulitis/erysipelas
usually not routinely recommended, possible if purulent infections occur after I&D, immunosuppressed (chemo, transplant), SIRS criteria
36
organism causing cellulitis from bite wounds
caused by 1. staphylo, strepto, 2. anaerobes (prevotella spp, peptostreptococcus spp.) 3. others (pasteurella multocida - animal; eikenella corrodens - human)
37
cellulitis from bite wounds Tx
1. Amoxi-Clav 2. Ceftriaxone/ cefuroxime + clinda/metronidazole 3. Cipro/levo + clinda/metronidazole (pen allergy) PO/IV based of severity
38
duration of cellulitis & erysipelas Tx
at least 5d, may extend if not significantly improved, | immunosuppressed may need 7-14d
39
DFI site of infection and its complications
soft tissue or bone infections below malleolus; areas of DFIs includes skin ulceration (peripheral neuropathy) or wound (trauma); complications would include hospitalisation, osteomyelitis which would lead to amputation
40
DFI Pathophysiology
1. neuropathy 2. vasculopathy 3. immunopathy
41
neuropathy of DFI
peripheral- reduced pain sensation and altered pain response motor- muscle imbalance autonomic- increase dryness, cracks and fissures
42
vasculopathy of DFI
early atherosclerosis; peripheral vascular disease; worsen by hyperglycemia and hyperlipidaemia
43
immunopathy of DFI
impaired immune response; increase susceptibility to infections; worsened by hyperglycemia
44
presentation of DFI
superficial ulcer, mild erythema; deep tissue infection, extensive erythema; infection of bone and fascia, purulent discharge
45
causative organism for DFI
typical polymicrobial (Staph/strep), gram neg (E. coli, Kleb, Proteus), anaerobes (ischemic or necrotic wounds- peptostrepto, veillonella, bacteriodes) is cultures needed for DFI - optional for mild D
46
is cultures needed for DFI
- optional for mild DFI; - moderate-severe DFI: deep tissue culture after cleansing and before starting antibiotics (if possible); avoid skin swabs - do not culture uninfected wounds